| Ytd | -75.38% | |
| 1y | -81.88% |
| Open | 1.07 | Prev Close | 1.08 | Low | 1.04 | High | 1.14 | Mkt Cap | 10.20M |
| Vol | 80.15K | Avg Vol | 339.60K | EPS | -0.99 | P/E | N/A | Forward P/E | -2.65 |
| Beta | 0.91 | Short Ratio | 0.60 | Inst. Own | 19.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 1.57 | 200-d Avg | 3.52 | 1yr Est | 3.15 |
NMTC News
Gainers SCWorx Corp. - Common Stock (NASDAQ:WORX) shares moved upwards by 48.8% to $6.25 during Thu
New NIH Award will Initially Provide NeuroOne Approximately $200,000 through April 2027 EDEN PRAIRIE
What happened NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) said preliminary fourth-quart
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"
Preliminary Fiscal Q4 2026 Product Revenue of $3.8 Million Preliminary Full-Year Product Revenue Up
NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free Report) and Innovative Eyewear (NASDAQ: LUCY
$10 Million in New Markets Tax Credit Financing for a New cold Storage and Refrigerated Logistics Fa
Shares of NeuroOne Medical Technologies Corporation (NASDAQ: NMTC - Get Free Report) have earned a c
EDEN PRAIRIE, Minn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (N
Gainers AEON Biopharma (AMEX:AEON) stock moved upwards by 8.9% to $0.32 during Thursday's after
Successful Large-Animal Procedures Build Momentum Toward Planned Launch of the StereoCED™ Platform f
$6 Million in New Markets Tax Credit Financing for the Acquisition, Renovation, and Equipping of a T
Maxim Group analyst Anthony Vendetti maintains NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy and
NeuroOne Medical Technologies Corporation (NMTC) Q3 2026 Earnings Call Transcript
NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call Transcript
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.25) per share which missed the
First Choice Healthcare Solutions (OTCMKTS:FCHS - Get Free Report) and NeuroOne Medical Technologies
NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Grow
Shares of NeuroOne Medical Technologies Corporation (NASDAQ: NMTC - Get Free Report) have been given
Jones Trading analyst Justin Walsh initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) with
NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.03) per share which beat the an
Aclarion (NASDAQ: ACON - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free
Cannlabs (OTCMKTS:CANL - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free
RIGL, CM and NMTC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 6th, 202
ILPT, NMTC, RIGL, RIO and BHP have been added to the Zacks Rank #1 (Strong Buy) List on January 6th,
NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.04) per share which met the ana
NeuroOne Medical Technologies Corporation - Special Call Company Participants David Rosa - President
Preliminary Results On October 6, 2024, the Company reported the following preliminary unaudited fi
Maxim Group analyst Anthony Vendetti initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) wi
NeuroOne Medical Tech (NASDAQ:NMTC) affirms FY2025 sales outlook from $8.00 million-$10.00 million t
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.03) per share which beat the an
Patient Treated with OneRF® Ablation System Previously Experienced up to 10 Seizures a DayEDEN PRAIR
NeuroOne Medical Tech (NASDAQ:NMTC) affirms FY2025 sales outlook from $8.00 million-$10.00 million t
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.07) per share. This is a 36.36